Page 1, 2, 3, References

References

1. Banauch G, Weiden M, Hall C, Cohen H, Aldrich T, Arcentales N, Kelly K, and Prezant D, Accelerated pulmonary function decline after World Trade Center particulate exposure in the New York City Fire Department workforce. Chest. 2005; 128:213S (abstr).
2. Banauch GI, Dhala A, Alleyne D, Alva R, Santhyadka G, Krasko A, Weiden M, Kelly KJ, Prezant DJ, Bronchial hyperreactivity and other inhalation lung injuries in rescue/recovery workers after the World Trade Center collapse. Crit Care Med. 2005; 33:S102-6.
3. Bell FP, Iverson F, Arnold D, Vidmar TJ, Long-term effects of Aroclor 1254 (PCBs) on plasma lipid and carnitine concentrations in rhesus monkey. Toxicology. 1994; 89:139-53.
4. Berge KG, Canner PL, Coronary drug project: experience with niacin. Coronary Drug Project Research Group. Eur J Clin Pharmacol. 1991; 40 Suppl 1:S49-51.
5. Butterworth RF, Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000; 32:171-80.
6. Center for Disease Control (CDC), Recognition of chemical illness associated with exposures to chemical agents United States, 2003. JAMA. 2003;290: 2247-2248.
7. de Freitas AS, Norstrom RJ, Turnover and metabolism of polychlorinated biphenyls in relation to their chemical structure and the movement of lipids in the pigeon. Can J Physiol Pharmacol. 1974 52:1080-94.
8. Feldman DM, Baron SL, Bernard BP, Lushniak BD, Banauch G, Arcentales N, Kelly KJ, Prezant DJ, Symptoms, respirator use, and pulmonary function changes among New York City firefighters responding to the World Trade Center disaster. Chest. 2004; 125:1256-64.
9. Fenech M, Micronutrients and genomic stability: a new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol. 2002; 40:1113-7.
10. Ferenci P, Treatment of hepatic encephalopathy. Indian J Gastroenterol. 2001; 20 Suppl 1:C90-4.
11. Findlay GM, DeFreitas AS, DDT movement from adipocyte to muscle cell during lipid utilization. Nature. 1971; 229:63-5.
12. Fireman EM, Lerman Y, Ganor E, Greif J, Fireman-Shoresh S, Lioy PJ, Banauch GI, Weiden M, Kelly KJ, Prezant DJ, Induced sputum assessment in New York City firefighters exposed to World Trade Center dust. Environ Health Perspect. 2004; 112:1564-9.
13. Gregersen P, Klausen H, Elsnab CU, Chronic toxic encephalopathy in solvent-exposed painters in Denmark 1976-1980: clinical cases and social consequences after a 5-year follow-up. Am J Ind Med. 1987; 11:399-417.
14. Herbert RLS, World Trade Center worker and volunteer medical screening program. Report of initial findings to the National Institute for Occupational Health and Safety of the Center for Disease Control and Prevention. 2003
15. Hosovski E, Mastelica Z, Sunderic D, Radulovic D, Mental abilities of workers exposed to aluminum. Med Lav. 1990; 81:119-23.
16. Houck P, Nebel D, Milham S Jr, Organic solvent encephalopathy: an old hazard revisited. Am J Ind Med 1992; 22:109-15.
17. Hubbard, L Ron, Clear Body Clear Mind, Bridge Publications, 2002.
18. Kelly GS, Peripheral metabolism of thyroid hormones: a review. Altern Med Rev. 2000; 5:306-33.
19. Kelly KJ, Connelly E, Reinhold GA, Byrne M, Prezant DJ, Assessment of health effects in New York City firefighters after exposure to polychlorinated biphenyls (PCBs) and polychlorinated dibenzofurans (PCDFs): the Staten Island Transformer Fire Health Surveillance Project. Arch Environ Health. 2002; 57:282-93.
20. Kilburn KH, Is the human nervous system most sensitive to environmental toxins? Arch Environ Health. 1989; 44:343-4.
21. Kilburn KH, Warsaw RH, Shields MG, Neurobehavioral dysfunction in firemen exposed to polychlorinated biphenyls (PCBs): possible improvement after detoxification. Arch Environ Health. 1989; 44:345-50.
22. Kilburn KH, Warshaw RH, Boylen CT, Thornton JC, Respiratory symptoms and functional impairment from acute (cross-shift) exposure to welding gases and fumes. Am J Med Sci. 1989; 298:314-9.
23. Kilburn KH, Warshaw RH, Hanscom B, Balance measured by head (and trunk) tracking and a force platform in chemically (PCB and TCE) exposed and referent subjects. Occup Environ Med. 1994; 51:381-5.
24. Klaidman LK, Mukherjee SK, Adams JD Jr, Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta. 2001; 1525:136-48.
25. Landrigan PJ, Lioy PJ, Thurston G, Berkowitz G, Chen LC, Chillrud SN, Gavett SH, Georgopoulos PG, Geyh AS, Levin S, Perera F, Rappaport SM, Small C, Health and environmental consequences of the world trade center disaster. Environ Health Perspect. 2004; 112:731-9.
26. Levin SM, Herbert R, Moline JM, Todd AC, Stevenson L, Landsbergis P, Jiang S, Skloot S, Physical Health Status of World Trade Center Rescue and Recovery Workers and Volunteers – New York City, July 2002 - August 2004. MMWR Morb Mortal Wkly Rep. 2004; 53:807-812.
27. Lin S, Reibman J, Bowers JA, Hwang SA, Hoerning A, Gomez MI, Fitzgerald EF, Upper respiratory symptoms and other health effects among residents living near the World Trade Center site after September 11, 2001. Am J Epidemiol. 2005; 162:499-507.
28. Lioy PJ, Gochfeld M, Lessons learned on environmental, occupational, and residential exposures from the attack on the World Trade Center. Am J Ind Med. 2002; 42:560-5.
29. Lioy PJ, Weisel CP, Millette JR, Eisenreich S, Vallero D, Offenberg J, Buckley B, Turpin B, Zhong M, Cohen MD, Prophete C, Yang I, Stiles R, Chee G, Johnson W, Porcja R, Alimokhtari S, Hale RC, Weschler C, Chen LC, Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001. Environ Health Perspect. 2002; 110:703-14.
30. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, Ruggieri S, Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci. 2004; 61:19-34.
31. Meyers CD, Kamanna VS, Kashyap ML, Niacin therapy in atherosclerosis. Curr Opin Lipidol. 2004; 15:659-65.
32. Miller JA, Cohen GS, Warshaw R, Thornton JC, Kilburn KH, Choice (CRT) and simple reaction times (SRT) compared in laboratory technicians: factors influencing reaction times and a predictive model. Am J Ind Med. 1989; 15:687-97.
33. Moser GA, McLachlan MS, A non-absorbable dietary fat substitute enhances elimination of persistent lipophilic contaminants in humans. Chemosphere. 1999; 39:1513-21.
34. Needleman HL, Lead levels and children's psychological performance. N Engl J Med. 1979; 301:163.
35. Niklasson M, Moller C, Odkvist LM, Ekberg K, Flodin U, Dige N, Skoldestig A, Are deficits in the equilibrium system relevant to the clinical investigation of solvent-induced neurotoxicity? Scand J Work Environ Health. 1997; 23:206-13.
36. Okamoto H, Ishikawa A, Yoshitake Y, Kodama N, Nishimuta M, Fukuwatari T, Shibata K, Diurnal variations in human urinary excretion of nicotinamide catabolites: effects of stress on the metabolism of nicotinamide. Am J Clin Nutr. 2003; 77:406-10.
37. Reibman J, Lin S, Hwang SA, Gulati M, Bowers JA, Rogers L, Berger KI, Hoerning A, Gomez M, Fitzgerald EF, The World Trade Center residents' respiratory health study: new-onset respiratory symptoms and pulmonary function. Environ Health Perspect. 2005; 113:406-11.
38. Rom WN, Weiden M, Garcia R, Yie TA, Vathesatogkit P, Tse DB, McGuinness G, Roggli V, Prezant D, Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med. 2002; 166:797-800.
39. Root DE, Lionelli GT, Excretion of a lipophilic toxicant through the sebaceous glands: A case report. J Toxicol Cutaneous Ocul Toxicol. 1987; 6:13-8.
40. Rozman K, Intestinal excretion of toxic substances. Arch Toxicol Suppl. 1985; 8:87-93.
41. Rozman K, Ballhorn L, Rozman T, Mineral oil in the diet enhances fecal excretion of DDT in the rhesus monkey. Drug Chem Toxicol. 1983; 6:311-6.
42. Rozman K, Rozman T, Greim H, Stimulation of nonbiliary, intestinal excretion of hexachlorobenzene in rhesus monkeys by mineral oil. Toxicol Appl Pharmacol. 1983; 70:255-61.
43. Rubic T, Trottmann M, Lorenz RL, Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol. 2004; 67:411-9.
44. Schnare, DW, Ben, M, and Shields, MG, Body Burden Reduction of PCBs, PBBs and Chlorinated Pesticides in Human Subjects. Ambio. 1984; 13(5-6):378-380.
45. Schnare DW, Denk G, Shields M, Brunton S, Evaluation of a detoxification regimen for fat stored xenobiotics. Med Hypotheses. 1982; 9:265-82.
46. Schnare DW, Robinson PC, Reduction of the human body burdens of hexachlorobenzene and polychlorinated biphenyls. IARC Sci Publ. 1986; 597-603.
47. Sen S, Jalan R, The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure. Perfusion. 2004; 19 Suppl 1:S43-8.
48. Sies H, Brigelius R, Wefers H, Muller A, Cadenas E, Cellular redox changes and response to drugs and toxic agents. Fundam Appl Toxicol. 1983; 3:200-8.
49. Sukdolova V, Negoita S, Hubicki L, DeCaprio A, Carpenter DO, The assessment of risk to acquired hypothyroidism from exposure to PCBs: a study among Akwesasne Mohawk women. Cent Eur J Public Health. 2000; 8:167-8.
50. Szema AM, Khedkar M, Maloney PF, Takach PA, Nickels MS, Patel H, Modugno F, Tso AY, Lin DH, Clinical deterioration in pediatric asthmatic patients after September 11, 2001. J Allergy Clin Immunol. 2004; 113:420-6.
51. Tretjak Z, Shields M, Beckmann SL, PCB reduction and clinical improvement by detoxification: An unexploited approach? Hum Exp Toxicol. 1990; 9:235-44.
52. Wang W, Basinger A, Neese RA, Shane B, Myong SA, Christiansen M, Hellerstein MK, Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production. Am J Physiol Endocrinol Metab. 2001; 280:E540-7.
53. Wierzbicki AS, Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention? Curr Med Res Opin. 2005; 21:299-306.
54. Yang J, Klaidman LK, Adams JD, Medicinal chemistry of nicotinamide in the treatment of ischemia and reperfusion. Mini Rev Med Chem. 2002; 2:125-34.